HBIO
Harvard Bioscience IncCompany with tickers: HBIO
CIK
1123494
CUSIP
416906204
Shares Outstanding
4,510,182
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $20,755,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | — | ||||
| Gross Profit | $12,244,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Expenses | $13,418,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $2,326,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-1,174,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-3,424,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.77 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.77 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |